Funck, Jr. Robert E. has filed 13 insider transactions across 1 company since February 2023.
Most recent transaction: a option exercise of 10097 shares of ABBOTT LABORATORIES ($ABT) on May 10, 2024.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 10, 2024 | ABBOTT LABORATORIES | $ABT | Funck, Jr. Robert E. | EXECUTIVE VICE PRESIDENT | M | Common shares without par value | 10097 | $47.00 | 280,703.0000 | 1,987,883,852 | 3.73% | 0.00% |
| May 10, 2024 | ABBOTT LABORATORIES | $ABT | Funck, Jr. Robert E. | EXECUTIVE VICE PRESIDENT | S | Common shares without par value | 10097 | $104.57 | 270,606.0000 | 1,987,883,852 | 3.60% | 0.00% |
| May 10, 2024 | ABBOTT LABORATORIES | $ABT | Funck, Jr. Robert E. | EXECUTIVE VICE PRESIDENT | M | Option (right to buy) | 10097 | $0.00 | 45,000.0000 | 1,987,883,852 | 18.33% | 0.00% |
| Feb. 29, 2024 | ABBOTT LABORATORIES | $ABT | Funck, Jr. Robert E. | EXECUTIVE VICE PRESIDENT | F | Common shares without par value | 11415 | $120.05 | 270,606.0000 | 1,987,883,852 | 4.05% | 0.00% |
| Feb. 21, 2024 | ABBOTT LABORATORIES | $ABT | Funck, Jr. Robert E. | EXECUTIVE VICE PRESIDENT | A | Common shares without par value | 24519 | $0.00 | 282,021.0000 | 1,987,883,852 | 9.52% | 0.00% |
| Feb. 21, 2024 | ABBOTT LABORATORIES | $ABT | Funck, Jr. Robert E. | EXECUTIVE VICE PRESIDENT | A | Option (right to buy) | 92137 | $0.00 | 92,137.0000 | 1,987,883,852 | 9999.99% | 0.00% |
| Sept. 13, 2023 | ABBOTT LABORATORIES | $ABT | Funck, Jr. Robert E. | EXECUTIVE VICE PRESIDENT | G | Common shares without par value | 20000 | $0.00 | 237,317.0000 | 1,986,519,278 | 7.77% | 0.00% |
| Sept. 13, 2023 | ABBOTT LABORATORIES | $ABT | Funck, Jr. Robert E. | EXECUTIVE VICE PRESIDENT | G | Common shares without par value | 10000 | $0.00 | 237,317.0000 | 1,986,519,278 | 4.40% | 0.00% |
| Sept. 13, 2023 | ABBOTT LABORATORIES | $ABT | Funck, Jr. Robert E. | EXECUTIVE VICE PRESIDENT | G | Common shares without par value | 10000 | $0.00 | 237,317.0000 | 1,986,519,278 | 4.40% | 0.00% |
| Feb. 28, 2023 | ABBOTT LABORATORIES | $ABT | Funck, Jr. Robert E. | EXECUTIVE VICE PRESIDENT | F | Common shares without par value | 11500 | $99.77 | 258,406.0000 | 1,986,519,278 | 4.26% | 0.00% |
| March 1, 2023 | ABBOTT LABORATORIES | $ABT | Funck, Jr. Robert E. | EXECUTIVE VICE PRESIDENT | S | Common shares without par value | 1264 | $100.70 | 257,142.0000 | 1,986,519,278 | 0.49% | 0.00% |
| Feb. 17, 2023 | ABBOTT LABORATORIES | $ABT | Funck, Jr. Robert E. | EXECUTIVE VICE PRESIDENT | A | Common shares without par value | 24419 | $0.00 | 269,906.0000 | 1,986,519,278 | 9.95% | 0.00% |
| Feb. 17, 2023 | ABBOTT LABORATORIES | $ABT | Funck, Jr. Robert E. | EXECUTIVE VICE PRESIDENT | A | Option (right to buy) | 96301 | $0.00 | 96,301.0000 | 1,986,519,278 | 9999.99% | 0.00% |